rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
1991-5-23
|
pubmed:abstractText |
In this study we investigated the expression of the 55 kDa (p55) and the 75 kDa (p75) TNF receptors in CD56+ NK cells and their role in NK and lymphokine-activated killer cells cell functions. By using mAb against the p55 and p75 TNF-R, NK cells were found to express both p55 and p75 upon activation, and both receptors were involved in the generation of lymphokine-activated killer cells activity. Proliferative activity of IL-2 stimulated NK cells was inhibited by anti-TNF-alpha mAb, indicating that endogenously produced TNF-alpha is important for optimal proliferation of NK cells. Furthermore, addition of rTNF-alpha increased the IL-2-induced proliferation of NK cells. mAb to p55 and p75 inhibited the IL-2-induced proliferation indicating that both TNF-R are involved in mediating this effect.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD56,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1767
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
146
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3045-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1707931-Antibodies, Monoclonal,
pubmed-meshheading:1707931-Antigens, CD,
pubmed-meshheading:1707931-Antigens, CD56,
pubmed-meshheading:1707931-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:1707931-Cytotoxicity, Immunologic,
pubmed-meshheading:1707931-Humans,
pubmed-meshheading:1707931-Immunity, Innate,
pubmed-meshheading:1707931-Interleukin-2,
pubmed-meshheading:1707931-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:1707931-Killer Cells, Natural,
pubmed-meshheading:1707931-Lymphocyte Activation,
pubmed-meshheading:1707931-Lymphocyte Subsets,
pubmed-meshheading:1707931-Receptors, Cell Surface,
pubmed-meshheading:1707931-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:1707931-Tumor Necrosis Factor-alpha
|
pubmed:year |
1991
|
pubmed:articleTitle |
Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
|
pubmed:affiliation |
Institute of Cancer Research, University of Trondheim, Norway.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|